Direct evidence to support the immunosurveillance concept in a human regressive melanoma., Journal of Clinical Investigation, vol.93, issue.4, pp.1397-1402, 1994. ,
DOI : 10.1172/JCI117116
URL : http://www.jci.org/articles/view/117116/files/pdf
Recent advances and hurdles in melanoma immunotherapy, Pigment Cell & Melanoma Research, vol.5, issue.Suppl 2, pp.711-723, 2009. ,
DOI : 10.4049/jimmunol.175.10.7046
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2009.00634.x/pdf
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.8, pp.711-723, 2010. ,
DOI : 10.1056/NEJMoa1003466
URL : http://www.nejm.org/doi/pdf/10.1056/NEJMoa1003466
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma, New England Journal of Medicine, vol.364, issue.26, pp.2517-2526, 2011. ,
DOI : 10.1056/NEJMoa1104621
Pembrolizumab versus Ipilimumab in Advanced Melanoma, New England Journal of Medicine, vol.372, issue.26, pp.2521-2532, 2015. ,
DOI : 10.1056/NEJMoa1503093
Mutation, New England Journal of Medicine, vol.372, issue.4, pp.320-330, 2015. ,
DOI : 10.1056/NEJMoa1412082
URL : https://hal.archives-ouvertes.fr/hal-00699117
Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma, Journal of Immunology, vol.138, pp.989-995, 1987. ,
Adoptive cell transfer as personalized immunotherapy for human cancer, Science, vol.385, issue.224, pp.62-68, 2015. ,
DOI : 10.1016/S0140-6736(14)61403-3
Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients, Clinical Cancer Research, vol.16, issue.9, pp.2646-2655, 2010. ,
DOI : 10.1158/1078-0432.CCR-10-0041
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes, Science, vol.298, issue.5594, pp.850-854, 2002. ,
DOI : 10.1126/science.1076514
URL : http://europepmc.org/articles/pmc1764179?pdf=render
-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma, Journal of Clinical Oncology, vol.31, issue.17, pp.2152-2159, 2013. ,
DOI : 10.1200/JCO.2012.46.6441
URL : http://europepmc.org/articles/pmc3731980?pdf=render
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients, Journal of Translational Medicine, vol.10, issue.1, p.169, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-2515
URL : https://translational-medicine.biomedcentral.com/track/pdf/10.1186/1479-5876-10-169?site=translational-medicine.biomedcentral.com
Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma, Journal of Immunotherapy, vol.35, issue.8, pp.615-620, 2012. ,
DOI : 10.1097/CJI.0b013e31826e8f5f
URL : http://europepmc.org/articles/pmc4467830?pdf=render
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies, Clinical Cancer Research, vol.19, issue.17, pp.4792-4800, 2013. ,
DOI : 10.1158/1078-0432.CCR-13-0380
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunology, Immunotherapy, vol.51, issue.10, pp.539-546, 2002. ,
DOI : 10.1007/s00262-002-0315-1
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunology, Immunotherapy, vol.12, issue.3, pp.1853-1860, 2007. ,
DOI : 10.4049/jimmunol.173.12.7125
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunology, Immunotherapy, vol.51, issue.10, pp.532-538, 2002. ,
DOI : 10.1007/s00262-002-0313-3
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival, Journal of Immunology Research, vol.20, issue.9, 2014. ,
DOI : 10.1245/s10434-013-2999-1
URL : http://doi.org/10.1155/2014/186212
Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells, The Journal of Immunology, vol.175, issue.7, pp.4797-4805, 2005. ,
DOI : 10.4049/jimmunol.175.7.4797
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 2009. ,
DOI : 10.1016/j.ejca.2008.10.026
High-Fold Expansion of Human Cytotoxic T-Lymphocytes Specific for Autologous Melanoma Cells for Use in Immunotherapy, Journal of Immunotherapy, vol.10, issue.6, pp.405-411, 1991. ,
DOI : 10.1097/00002371-199112000-00003
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunology, Immunotherapy, vol.50, issue.3, pp.134-140, 2001. ,
DOI : 10.1007/PL00006683
Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangements, European Journal of Immunology, vol.1, issue.4, pp.825-831, 1990. ,
DOI : 10.1002/eji.1830200417
Comparison of three culture media for the establishment of melanoma cell lines, Cytotechnology, vol.164, issue.5, pp.403-412, 2010. ,
DOI : 10.4049/jimmunol.164.1.495
Melanoma gene expression and clinical course, Archives of Dermatological Research, vol.12, issue.2, pp.673-679, 2009. ,
DOI : 10.1093/jnci/94.11.805
Detection of intracellular cytokines by flow cytometry, Journal of Immunological Methods, vol.159, issue.1-2, pp.197-207, 1993. ,
DOI : 10.1016/0022-1759(93)90158-4
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?, Cancer Immunology, Immunotherapy, vol.14, issue.8, pp.1081-1091, 2014. ,
DOI : 10.1016/S1470-2045(12)70539-9
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-??) in metastatic melanoma patients, Cancer Immunology, Immunotherapy, vol.2013, issue.7, pp.805-815, 2015. ,
DOI : 10.1155/2013/932318
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy, Proceedings of the National Academy of Sciences of the United States of America, pp.725-732, 2002. ,
DOI : 10.1097/CJI.0b013e3181f05b91
expansion of tumor-infiltrating lymphocytes in melanoma patients, Experimental Dermatology, vol.168, issue.5, pp.436-445, 2008. ,
DOI : 10.4049/jimmunol.168.10.4864
Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer, Blood, vol.119, issue.24, pp.5688-5696, 2012. ,
DOI : 10.1182/blood-2011-10-386482
URL : http://www.bloodjournal.org/content/bloodjournal/119/24/5688.full.pdf